Is infliximab safe to use while breastfeeding?

World Journal of Gastroenterology

Volumn 14, Issue 19, 2008, Pages 3085-3087

  Stengel, Joel Z ^a   Arnold, Hays L ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Breast feeding; Crohn's disease; Inflammatory bowel disease; Monoclonal antibodies; Pregnancy; Ulcerative colitis

Indexed keywords

INFLIXIMAB; MESALAZINE;

ADULT; ARTICLE; BREAST FEEDING; CASE REPORT; COLON CROHN DISEASE; DRUG INFUSION; DRUG MILK LEVEL; DRUG MONITORING; DRUG SAFETY; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MALE; PATIENT COUNSELING; PREGNANCY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; TERATOGENICITY;

EID: 48049101407     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3085     Document Type: Article

References (15)

1. Jospe ES, Peppercorn MA. Inflammatory bowel disease and pregnancy: a review. Dig Dis 1999; 17: 201-207
2. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006; 4: 1255-1258
3. Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol 2001; 96: 2274-2275
4. Remicade product information. In: Physicians desk reference. 58th ed. Montvale, NJ: Medical Economics Company, Inc, 2004: 1145-1148
5. Reddy JG, Loftus EV Jr. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am 2006; 35: 837-855
6. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21: 3365-3369
7. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005; 21: 733-738
8. Friedman S, Regueiro MD. Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 265-73, xii
9. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-2392
10. Tursi A. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease. Dig Liver Dis 2006; 38: 439-440
11. Humira (adalimumab) [prescribing information]. North Chicago, IL: Abbott Laboratories, 2005
12. Sanchez Munoz D, Hoyas Pablos E, Ramirez Martin Del Campo M, Nunez Hospital D, Guerrero Jimenez P. [Term pregnancy in a patient with Crohn's disease under treatment with adalimumab] Gastroenterol Hepatol 2005; 28: 435
13. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005; 54: 890
14. Sills ES, Perloe M, Tucker MJ, Kaplan CR, Palermo GD. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol 2001; 46: 366-368
15. Ostensen M, Eigenmann GO. Etanercept in breast milk. J Rheumatol 2004; 31: 1017-1018